HKSE:0241

Alibaba Health Information Technology Limited · HKSE · Healthcare · HKD · FY for 2026

Figures on this page computed 2026-11-08 13:34 UTC

Last close

n/aHKD

Market data

  • 22.0xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • computed
    • Computed from the filing for 2026
  • 12.8%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 5.7%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 3.6%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 0.003Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • computed

Five bars, one line

lens 7 of 9
1.99x
4.33x
2.05x
0.22x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2026
Computed2026
Computed2026
Computed2026
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2026

  • Sales1.99x

    Its own average over 10 years, 17.23B.

  • Profit4.33x

    Its own average over 10 years, 446.8M.

  • Free cash flow2.05x

    Its own average over 10 years, 597.5M.

  • Debt0.22x

    Its own average over 9 years, 266.5M.

  • Pricen/a

    Its own average over 0 years. Market data

Profit is furthest from its own average, at 4.33 times.

Sales is 1.99 times its own 10-year average; Profit is 4.33 times its own 10-year average; Free cash flow is 2.05 times its own 10-year average; Debt is 0.22 times its own 9-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

  • Sales against its own 10-year average1.99
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    CNY
  • Profit against its own 10-year average4.33
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    CNY
  • Free cash flow against its own 10-year average2.05
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    CNY
  • Debt against its own 9-year average0.22
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    CNY
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    HKD

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.